Wilson Therapeutics AB, a privately-held biopharmaceutical company, today announced its sponsorship of the first annual Big Walk on Wilson's (BIG WOW). The event will take place on September 19, 2015 in sixteen cities across North America to increase awareness of Wilson's Disease and raise funds for the Wilson Disease Association.
"Although Wilson's Disease has been recognized for more than one hundred years, many patients have a delayed diagnosis or a misdiagnosis causing disease progression, potentially irreversible organ damage, and even death. We need to raise awareness of Wilson's Disease in order for more patients to be diagnosed at an earlier stage, receive proper treatment, and potentially reduce its debilitating effects. We are thrilled that Wilson Therapeutics is generously supporting this effort," said Mary Graper, President of the Wilson Disease Association.
Christopher Simopoulos, MD, one of the initiators of the BIG WOW continued: "As the father of three sons diagnosed with Wilson's, I have personal experience with the importance of an early diagnosis. With this initiative, my family and I hope that we will be able to raise awareness of Wilson's Disease among the public and healthcare community so that more patients are diagnosed earlier and we can reduce the well-known consequences of untreated Wilson's Disease."
Wilson Therapeutics is sponsoring this important event as part of its commitment to improve the lives of patients with Wilson's Disease.
A new era of targeted therapy with antibody–drug conjugates